Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
Yang J, Bahk WM, Cho HS, Jeon YW, Jon DI, Jung HY, Kim CH, Kim HC, Kim YK, Kim YH, Kwon JS, Lee SY, Lee SH, Yi JS, Yoon BH, Kim SH.
Yang J, et al. Among authors: kim yh, kim yk, kim ch, kim sh, kim hc.
Clin Neuropharmacol. 2010 Jul;33(4):169-75. doi: 10.1097/WNF.0b013e3181dcda50.
Clin Neuropharmacol. 2010.
PMID: 20661022
Clinical Trial.